Syntax Bio
- Headquarters
- Chicago, Illinois
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- syntaxbio.com
- Total Funding
- $15.0M
- Last Round
- $15.0M SeedSep 2024
About
Develops a CRISPR-based platform to program and accelerate stem cell differentiation, enabling scalable regenerative cell therapies for biopharma partners.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account